ES2182914T3 - Inmunopotenciacion inducida de quitosan. - Google Patents
Inmunopotenciacion inducida de quitosan.Info
- Publication number
- ES2182914T3 ES2182914T3 ES95934516T ES95934516T ES2182914T3 ES 2182914 T3 ES2182914 T3 ES 2182914T3 ES 95934516 T ES95934516 T ES 95934516T ES 95934516 T ES95934516 T ES 95934516T ES 2182914 T3 ES2182914 T3 ES 2182914T3
- Authority
- ES
- Spain
- Prior art keywords
- quitosan
- immunopotentiation
- induced
- compositions
- induced immunopotentiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
SE MUESTRAN METODOS Y COMPOSICIONES PARA LA POTENCIACION DE UNA RESPUESTA INMUNE QUE INCORPORAN QUITOSANO COMO ADYUVANTE DE INMUNOPOTENCIACION. LA ADMINISTRACION DE LAS COMPOSICIONES DE LA INVENCION SE EFECTUA POR VARIAS VIAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31153294A | 1994-09-23 | 1994-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2182914T3 true ES2182914T3 (es) | 2003-03-16 |
Family
ID=23207335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95934516T Expired - Lifetime ES2182914T3 (es) | 1994-09-23 | 1995-09-25 | Inmunopotenciacion inducida de quitosan. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0789590B1 (es) |
JP (1) | JP3365635B2 (es) |
AT (1) | ATE223235T1 (es) |
AU (1) | AU688603B2 (es) |
CA (1) | CA2200550A1 (es) |
DE (1) | DE69528074T2 (es) |
DK (1) | DK0789590T3 (es) |
ES (1) | ES2182914T3 (es) |
PT (1) | PT789590E (es) |
WO (1) | WO1996009805A2 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9525083D0 (en) | 1995-12-07 | 1996-02-07 | Danbiosyst Uk | Vaccine compositions |
EP1011730A2 (en) * | 1996-10-07 | 2000-06-28 | Edge Biosystems, Inc. | Targeted addition of soluble polymers to recombinant proteins |
AUPO517897A0 (en) * | 1997-02-19 | 1997-04-11 | Csl Limited | Chelating immunostimulating complexes |
AU771525B2 (en) * | 1997-03-25 | 2004-03-25 | Zonagen, Inc. | Chitosan induced immunopotentiation |
CA2255867C (en) * | 1997-03-25 | 2008-02-05 | Zonagen, Inc. | Chitosan induced immunopotentiation |
US5980912A (en) * | 1997-03-25 | 1999-11-09 | Zonagen, Inc. | Chitosan induced immunopotentiation |
GB9725084D0 (en) | 1997-11-28 | 1998-01-28 | Medeva Europ Ltd | Vaccine compositions |
US6280742B1 (en) * | 1998-06-17 | 2001-08-28 | Zonagen, Inc. | Methods and materials for the treatment of prostatic carcinoma |
WO2000015253A1 (en) * | 1998-09-17 | 2000-03-23 | Zonagen, Inc. | Human chorionic gonadotropin vaccines |
AU3879200A (en) * | 1999-08-16 | 2001-03-13 | Zonagen, Inc. | Methods and materials for the treatment of prostatic carcinoma |
US7022830B2 (en) | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
KR100801123B1 (ko) | 2000-08-17 | 2008-02-05 | 트리펩 아베 | 리바비린 함유 백신 및 이것의 사용 방법 |
US6858590B2 (en) | 2000-08-17 | 2005-02-22 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
ITMI20010347A1 (it) | 2001-02-21 | 2002-08-21 | Grisotech S A | Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale |
EP1356826A1 (en) * | 2002-04-22 | 2003-10-29 | BIOMAY Produktions- und Handels- Aktiengesellschaft | Microparticles comprising carbohydrate beads covalently linked with allergen |
JP2009508852A (ja) * | 2006-01-23 | 2009-03-05 | クワンジュ インスティチュート オブ サイエンス アンド テクノロジー | 薬理活性物質と粘膜粘着性高分子とが共有結合されたコンジュゲート及びこれを用いた薬理活性物質の経粘膜運搬方法 |
US8071561B2 (en) | 2007-08-16 | 2011-12-06 | Chrontech Pharma Ab | Immunogen platform |
EP3006047B1 (en) * | 2013-06-06 | 2019-08-07 | Toppan Printing Co., Ltd. | Needle body |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5639022A (en) * | 1979-09-05 | 1981-04-14 | Hayashibara Biochem Lab Inc | Preparation of vaccine |
JPS5823847B2 (ja) * | 1981-02-06 | 1983-05-18 | 株式会社 林原生物化学研究所 | 抗ヒト蛋白質抗体の製造方法 |
SE8204244L (sv) * | 1982-07-09 | 1984-01-10 | Ulf Schroder | Kristalliserad kolhydratsmatris for biologiskt aktiva substanser |
CA1261264A (en) * | 1984-11-29 | 1989-09-26 | Shigeo Suzuki | Immunopotentiating agents and method |
JPH0747546B2 (ja) * | 1985-09-11 | 1995-05-24 | イハラケミカル工業株式会社 | アジユバント又は免疫増強剤 |
US4935147A (en) * | 1985-12-20 | 1990-06-19 | Syntex (U.S.A.) Inc. | Particle separation method |
JP2594123B2 (ja) * | 1987-09-12 | 1997-03-26 | 株式会社林原生物化学研究所 | 減感作剤 |
DE4007315A1 (de) * | 1990-03-08 | 1991-09-12 | Behringwerke Ag | Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen |
JP2975632B2 (ja) * | 1990-03-30 | 1999-11-10 | 生化学工業株式会社 | グリコサミノグリカン修飾プロテイン |
JP3150991B2 (ja) * | 1991-04-10 | 2001-03-26 | 協和醗酵工業株式会社 | ハイブリドーマの製造法 |
JP3263857B2 (ja) * | 1992-04-16 | 2002-03-11 | 太陽化学株式会社 | 抗体産生組成物および抗体産生法 |
CA2153391C (en) * | 1993-01-11 | 2000-08-15 | Kenneth Rock | Inducing cytotoxic t lymphocyte responses |
-
1995
- 1995-09-25 DE DE69528074T patent/DE69528074T2/de not_active Expired - Fee Related
- 1995-09-25 JP JP51192196A patent/JP3365635B2/ja not_active Expired - Fee Related
- 1995-09-25 WO PCT/US1995/012189 patent/WO1996009805A2/en active IP Right Grant
- 1995-09-25 AU AU36830/95A patent/AU688603B2/en not_active Ceased
- 1995-09-25 AT AT95934516T patent/ATE223235T1/de not_active IP Right Cessation
- 1995-09-25 ES ES95934516T patent/ES2182914T3/es not_active Expired - Lifetime
- 1995-09-25 EP EP95934516A patent/EP0789590B1/en not_active Expired - Lifetime
- 1995-09-25 PT PT95934516T patent/PT789590E/pt unknown
- 1995-09-25 DK DK95934516T patent/DK0789590T3/da active
- 1995-09-25 CA CA002200550A patent/CA2200550A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0789590B1 (en) | 2002-09-04 |
WO1996009805A2 (en) | 1996-04-04 |
AU688603B2 (en) | 1998-03-12 |
CA2200550A1 (en) | 1996-04-04 |
JP2001509774A (ja) | 2001-07-24 |
PT789590E (pt) | 2002-12-31 |
DK0789590T3 (da) | 2002-11-04 |
AU3683095A (en) | 1996-04-19 |
DE69528074T2 (de) | 2003-04-30 |
ATE223235T1 (de) | 2002-09-15 |
WO1996009805A3 (en) | 1996-07-25 |
DE69528074D1 (de) | 2002-10-10 |
JP3365635B2 (ja) | 2003-01-14 |
EP0789590A2 (en) | 1997-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2182914T3 (es) | Inmunopotenciacion inducida de quitosan. | |
FI972945A (fi) | Antigeenien antamiseen soveltuvia koostumuksia | |
BR9907995A (pt) | Métodos imunológicos para modular miostatina em sujeitos vertebrados | |
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
BG99261A (en) | Steroid glycosides for the treatment of hyperchlesterolemia | |
NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
FR2762843B1 (fr) | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
HU9203871D0 (en) | Pharmaceutical application of certain cistine derivatives | |
ATE203519T1 (de) | Chinolinderivate als antimalariamittel | |
MD1560G2 (ro) | Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri | |
NO911065L (no) | Fremgangsmaate for fremstilling av lipopeptidderivater. | |
ATE207076T1 (de) | Ara-c derivate | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
IT1270618B (it) | Proteine ad attivita' antitumorale | |
FI892222A (fi) | Peptidalkoholer med antikoagulantverkan. | |
IT9019323A0 (it) | Procedimento di preparazione di l-a-glicerilfosforil-d-myoinositolo e suoi sali da fosfatidi grezzi o parzialmente purificati | |
CA2255867A1 (en) | Chitosan induced immunopotentiation | |
DK0977871T3 (da) | Neurotrypsin | |
EP1131338A4 (en) | PROCESS FOR PRODUCING HIGHLY PURIFIED INVASINATED PROTEIN AND USE OF SUCH PROTEIN | |
WO2001035994A3 (en) | Chitosan induced immunopotentiation | |
ATE223427T1 (de) | Modifizierte kojibioside analoge | |
IL101540A0 (en) | Method and composition for the treatment of herpes related disorders | |
FR2708855B1 (fr) | Compositions pharmaceutiques immunoadjuvantes ou immunostimulantes. | |
MX9202293A (es) | Composicion de vacuna no-irritante. |